Table 3 Univariate and multivariate analyses showing significant predictive factors of mortality in the propensity score–matched patients (n = 156)
From: Hepatitis C virus genotype affects survival in patients with hepatocellular carcinoma
Variable | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
P | HR (95% CI) | P | HR (95% CI) | |
Non-genotype 2 | 0.007 | 1.93 (1.19–3.13) | 0.004 | 2.19 (1.29–3.71) |
AFP > 200 ng/mL | < 0.001 | 3.11 (1.86–5.20) | 0.001 | 2.93 (1.55–5.55) |
MELD score per point | < 0.001 | 1.15 (1.08–1.23) | < 0.001 | 1.23 (1.11–1.37) |
Child Pugh class B or C | < 0.001 | 2.71 (1.66–4.54) | 0.287 | 0.67 (0.31–1.41) |
SVR | < 0.001 | 0.150 (0.06–0.41) | 0.002 | 0.18 (0.06–0.52) |
BCLC Stage 0 | Reference | Reference | ||
 Stage A | 0.235 | 1.78 (0.69–4.59) | 0.021 | 3.32 (1.20–9.19) |
 Stage B | 0.001 | 5.30 (1.97–14.38) | 0.001 | 6.06 (2.08–17.69) |
 Stage C | < 0.001 | 13.16 (4.70–36.87) | < 0.001 | 18.83 (6.06–58.52) |
 Stage D | < 0.001 | 25.08 (6.45–97.56) | 0.004 | 8.87 (2.02–39.02) |